SmartPill on course with monitoring pill
This article was originally published in Clinica
Still on course to enter the gastrointestinal diagnostics market by 2006, SmartPill said it expects to complete US clinical trials this month of its ingestable capsule for gastroparesis, a condition characterised by the inability to empty the stomach.
You may also be interested in...
An upturn in M&A activity across the whole healthcare sector is expected in 2021, with the COVID-19 pandemic and the associated development of a vaccine shining a light on the sector, says a recent survey by Jefferies.
Australian patients with phototoxicity due to the rare condition EPP will now have their first treatment option – provided the drug's developer, Clinuvel, secures reimbursement under the Pharmaceutical Benefits Scheme.
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.